Abstract
Coagulation disorders are common in intensive care patients and may range from isolated thrombocytopenia or prolonged global clotting tests to complex defects, such as disseminated intravascular coagulation. There can be a wide variety of causes for coagulation derangements in critically ill patients, and each of the underlying disorders may require specific therapeutic management. Hence, an appropriate differential diagnosis and the initiation of adequate (supportive) treatment strategies are crucial to a reduction in morbidity and mortality in critically ill patients with coagulation abnormalities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ahmed A, Kojicic M, Herasevich V et al (2009) Early identification of patients with or at risk of acute lung injury. Neth J Med 67:268–271
Bailey B, Amre DK, Gaudreault P (2003) Fulminant hepatic failure secondary to acetaminophen poisoning: a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 31:299–305
Bernard GR, Vincent JL, Laterre PF et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709
Dhainaut JF, Yan SB, Joyce DE et al (2004) Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2:1924–1933
Eckle I, Seitz R, Egbring R et al (1991) Protein C degradation in vitro by neutrophil elastase. Biol Chem Hoppe Seyler 372:1007–1013
Edmunds LH (2001) Hemostatic problems in surgical patients. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds) Hemostasis and thrombosis. Basic principles and clinical practice. Lippincott William & Wilkins, Philadelphia, pp 1031–1043
Esmon CT (1987) The regulation of natural anticoagulant pathways. Science 235:1348–1352
Esmon CT (2000) The endothelial cell protein C receptor. Thromb Haemost 83:639–643
Esmon CT (2001) Role of coagulation inhibitors in inflammation. Thromb Haemost 86:51–56
Faust SN, Levin M, Harrison OB et al (2001) Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345:408–416
Folman CC, Linthorst GE, van Mourik J et al (2000) Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis? Thromb Haemost 83:923–930
Francois B, Trimoreau F, Vignon P et al (1997) Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 103:114–120
Greaves M, Preston FE (2001) Approach to the bleeding patient. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds) Hemostasis and thrombosis. Basic principles and clinical practice. Lip**cott William&Wilkins, Philadelphia, pp 1031–1043
Griffin JH, Fernandez JA, Gale AJ et al (2007) Activated protein C. J Thromb Haemost 5(Suppl 1):73–80: 73–80
Hellstern P, Muntean W, Schramm W et al (2002) Practical guidelines for the clinical use of plasma. Thromb Res 107(Suppl 1):S53
Hermanides J, Huijgen R, Henny CP et al (2009) Hip surgery sequentially induces stress hyperglycaemia and activates coagulation. Neth J Med 67:226–229
Hirsh J, Heddle N, Kelton JG (2004) Treatment of heparin-induced thrombocytopenia: a critical review. Arch Intern Med 164:361–369
Levi M (2012) Safety of prohemostatic interventions. Semin Thromb Hemost 38:282–288
Levi M, Lowenberg EC (2008) Thrombocytopenia in critically ill patients. Semin Thromb Hemost 34:417–424
Levi M, Opal SM (2006) Coagulation abnormalities in critically ill patients. Crit Care 10:222
Levi M, ten Cate H (1999) Disseminated intravascular coagulation. N Engl J Med 341:586–592
Levi M, van der Poll T (2008) The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients. Semin Thromb Hemost 34:459–468
Levi M, Cromheecke ME, de Jonge E et al (1999) Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354:1940–1947
Levi M, de Jonge E, van der Poll T (2001) Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med 29:S90–S94
Levi M, van der Poll T, Buller HR (2004) Bidirectional relation between inflammation and coagulation. Circulation 109:2698–2704
Levi M, Nieuwdorp M, van der Poll T et al (2008) Metabolic modulation of inflammation-induced activation of coagulation. Semin Thromb Hemost 34:26–32
Levi M, Toh CH, Thachil J et al (2009) Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol 145:24–33
Levi M, Levy JH, Andersen HF et al (2010) Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 363:1791–1800
Levi M, Opal S (2010) Coagulation abnormalities in the critically ill. Surgical Intensive Care Medicine. O’Donnell J, Nacul F, Springer US: 371–378
Levi M, Schouten M, van der Poll T (2008) Sepsis, coagulation, and antithrombin: old lessons and new insights. Semin Thromb Hemost 34:742–746
Mannucci PM (1997) Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 90:2515–2521
Mannucci PM, Levi M (2007) Prevention and treatment of major blood loss. N Engl J Med 356:2301–2311
Mavrommatis AC, Theodoridis T, Orfanidou A et al (2000) Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 28:451–457
Mesters RM, Helterbrand J, Utterback BG et al (2000) Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications. Crit Care Med 28:2209–2216
Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589–600
Nawroth PP, Stern DM (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163:740–745
Porte RJ, Molenaar IQ, Begliomini B et al (2000) Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet 355:1303–1309
Ranieri VM, Thompson BT, Barie PS et al (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055–2064
Saito H, Maruyama I, Shimazaki S et al (2007) Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 5:31–41
Schultz MJ (2009) Early recognition of critically ill patients. Neth J Med 67:266–267
Shakur H, Roberts I, Bautista R et al (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376:23–32
Shorr AF, Thomas SJ, Alkins SA et al (2002) D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest 121:1262–1268
Stephan F, Hollande J, Richard O et al (1999) Thrombocytopenia in a surgical ICU. Chest 115:1363–1370
Strauss R, Wehler M, Mehler K et al (2002) Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 30:1765–1771
Taylor FBJ, Stearns-Kurosawa DJ, Kurosawa S et al (2000) The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 95:1680–1686
Taylor FBJ, Toh CH, Hoots WK et al (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327–1330
Thachil J, Toh CH, Levi M et al (2012) The withdrawal of activated protein C from the use in patients with severe sepsis and DIC. Br J Haematol 37:10–2141
Tsai HM (2003) Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura. Arterioscler Thromb Vasc Biol 23:388–396
van den Born BJ, van der Hoeven NV, Groot E et al (2008) Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertension 51:862–866
Vanderschueren S, De Weerdt A, Malbrain M et al (2000) Thrombocytopenia and prognosis in intensive care. Crit Care Med 28:1871–1876
Vary TC, Kimball SR (1992) Regulation of hepatic protein synthesis in chronic inflammation and sepsis. Am J Physiol 262:C445–C452
Verma AK, Levine M, Shalansky SJ et al (2003) Frequency of heparin-induced thrombocytopenia in critical care patients. Pharmacotherapy 23:745–753
Vlaar AP, Schultz MJ, Juffermans NP (2009) Transfusion-related acute lung injury: a change of perspective. Neth J Med 67:320–326
Warkentin TE (2003) Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121:535–555
Warkentin TE, Aird WC, Rand JH (2003) Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program 70:497–519
Wheeler AP, Bernard GR (1999) Treating patients with severe sepsis. N Engl J Med 340:207–214
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Levi, M. (2015). Coagulation Disorders in Intensive Care Patients. In: Marcucci, C., Schoettker, P. (eds) Perioperative Hemostasis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55004-1_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-55004-1_22
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-55003-4
Online ISBN: 978-3-642-55004-1
eBook Packages: MedicineMedicine (R0)